Start small and build gradually
Zhao LH, Yin Y, Yang D, Liu B, Hou L, Wang X, et al
Cell Death Dis 10 (10), 753
Advancing Inclusive Aesthetics Hyperpigmentation remains one of the most common and difficult skin concerns, especially for patients with higher melanin content
The Noom Microdose GLP-1 Program was designed to address this issue by introducing GLP-1s gradually and sustaining them at a microdose level, as part of a larger holistic behavior change platform.
GLP-1 receptor agonists, developed initially as diabetes medications, have gained popularity due to their ability to suppress appetite and reduce the speed of gastric emptying, resulting in weight loss (5)